Las nuevas inscripciones bajo la Ley de Cuidado de Salud a Bajo Precio (ACA) parecen ser hasta un millón menos que el número récord del año pasado, especialmente por problemas con el programa que enfrenta la saliente administración Biden. La reelección de Donald Trump para un segundo mandato ha generado incertidumbre sobre el futuro de…
María Sánchez emigró al área de Chicago desde México hace unos 30 años. Ahora, a sus 87, sigue viviendo en Estados Unidos sin papeles. Como muchos inmigrantes de larga data, ha trabajado —y pagado impuestos, incluyendo para Medicare— durante todo ese tiempo. Pero Sánchez nunca tuvo seguro médico, y cuando cumplió 65, no pudo inscribirse…
FDA leaders under President Donald Trump are moving to abandon a decades-old policy of asking outside experts to review drug applications, a move critics say would shield the agency’s decisions from public scrutiny. The agency “would like to get away” from assembling panels of experts to examine and vote on individual drugs, because “I don’t…
Roche’s Tecentriq Hybreza is a subcutaneously injectable formulation of the cancer drug Tecentriq while Ocrevus Zunovo is an injectable version of multiple sclerosis drug Ocrevus. Each is administered in minutes compared to an hour or more for infused therapies. The post Roche Welcomes FDA Approvals for Injectable Versions of MS and Cancer Drugs appeared first…
The 2nd Annual Northeast Division Conference & Trade Show was a resounding success, bringing together more than 250 Environmental Services (EVS) leaders, industry vendors, and guest speakers for an event focused on best practices, innovation, and the future of EVS. The trade show was planned and led by the RDO Council, a group of leaders…
It’s not the flashiest technologies or rapid-speed AI breakthroughs that can do it. It’s the technologies laser-focused on the unglamorous but all-consuming coordination problems that suck up medical staff’s time, stress them out, and compromise patient care. The post Innovation Fatigue is Rampant: What’s the Rx to Fix It? appeared first on MedCity News.
President Donald Trump recently announced an executive order on IVF. But it doesn’t actually do much yet. Rather, it’s asking for a list of recommendations to protect IVF access. The post Trump’s IVF Executive Order Doesn’t Actually Achieve Much — Yet appeared first on MedCity News.
For nearly three years, Eric Tennant endured chemotherapy infusions, rounds of radiation, biopsies, and hospitalizations that left him weak and depleted. “It’s good to be home,” he said after one hospital stay in early June, “yet I’m tired and ready to get on with things.” In 2023, Tennant, of Bridgeport, West Virginia, was diagnosed with…
That is the title of a helpful article by Karnon and Haji Ali Afzali (Pharmacoeconomics 2014) with a subtitle A Review and Critique of the Costs and Benefits of DES. The paper starts by highlighting the 3 most common types of models: decision trees, Markovian cohort models, and individual level models. Decisions trees are useful…
At DiMe’s Healthcare 2030 Summit, four healthcare leaders shared the innovations they believe could most improve care, from AI-driven solutions to reduce medical errors to stronger primary care relationships that could save billions. The post 4 Execs’ Wishes for a Better Healthcare Future appeared first on MedCity News.